1463 related articles for article (PubMed ID: 18254031)
1. Glucocorticoid corticosteroids for Duchenne muscular dystrophy.
Manzur AY; Kuntzer T; Pike M; Swan A
Cochrane Database Syst Rev; 2008 Jan; (1):CD003725. PubMed ID: 18254031
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid corticosteroids for Duchenne muscular dystrophy.
Manzur AY; Kuntzer T; Pike M; Swan A
Cochrane Database Syst Rev; 2004; (2):CD003725. PubMed ID: 15106215
[TBL] [Abstract][Full Text] [Related]
3. Corticosteroids for the treatment of Duchenne muscular dystrophy.
Matthews E; Brassington R; Kuntzer T; Jichi F; Manzur AY
Cochrane Database Syst Rev; 2016 May; 2016(5):CD003725. PubMed ID: 27149418
[TBL] [Abstract][Full Text] [Related]
4. Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews.
Oaklander AL; Lunn MP; Hughes RA; van Schaik IN; Frost C; Chalk CH
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010369. PubMed ID: 28084646
[TBL] [Abstract][Full Text] [Related]
5. Effect of Different Corticosteroid Dosing Regimens on Clinical Outcomes in Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial.
Guglieri M; Bushby K; McDermott MP; Hart KA; Tawil R; Martens WB; Herr BE; McColl E; Speed C; Wilkinson J; Kirschner J; King WM; Eagle M; Brown MW; Willis T; Griggs RC; ; Straub V; van Ruiten H; Childs AM; Ciafaloni E; Shieh PB; Spinty S; Maggi L; Baranello G; Butterfield RJ; Horrocks IA; Roper H; Alhaswani Z; Flanigan KM; Kuntz NL; Manzur A; Darras BT; Kang PB; Morrison L; Krzesniak-Swinarska M; Mah JK; Mongini TE; Ricci F; von der Hagen M; Finkel RS; O'Reardon K; Wicklund M; Kumar A; McDonald CM; Han JJ; Joyce N; Henricson EK; Schara-Schmidt U; Gangfuss A; Wilichowski E; Barohn RJ; Statland JM; Campbell C; Vita G; Vita GL; Howard JF; Hughes I; McMillan HJ; Pegoraro E; Bello L; Burnette WB; Thangarajh M; Chang T
JAMA; 2022 Apr; 327(15):1456-1468. PubMed ID: 35381069
[TBL] [Abstract][Full Text] [Related]
6. Interventions for increasing ankle range of motion in patients with neuromuscular disease.
Rose KJ; Burns J; Wheeler DM; North KN
Cochrane Database Syst Rev; 2010 Feb; (2):CD006973. PubMed ID: 20166090
[TBL] [Abstract][Full Text] [Related]
7. Rehabilitation interventions for foot drop in neuromuscular disease.
Sackley C; Disler PB; Turner-Stokes L; Wade DT; Brittle N; Hoppitt T
Cochrane Database Syst Rev; 2009 Jul; (3):CD003908. PubMed ID: 19588347
[TBL] [Abstract][Full Text] [Related]
8. Interventions to prevent and treat corticosteroid-induced osteoporosis and prevent osteoporotic fractures in Duchenne muscular dystrophy.
Bell JM; Shields MD; Watters J; Hamilton A; Beringer T; Elliott M; Quinlivan R; Tirupathi S; Blackwood B
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010899. PubMed ID: 28117876
[TBL] [Abstract][Full Text] [Related]
9. Antioxidants to prevent respiratory decline in people with Duchenne muscular dystrophy and progressive respiratory decline.
Garegnani L; Hyland M; Roson Rodriguez P; Escobar Liquitay CME; Franco JV
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD013720. PubMed ID: 34748221
[TBL] [Abstract][Full Text] [Related]
10. Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy.
Hughes RA; Mehndiratta MM
Cochrane Database Syst Rev; 2015 Jan; 1():CD002062. PubMed ID: 25561247
[TBL] [Abstract][Full Text] [Related]
11. Corticosteroid therapy for nephrotic syndrome in children.
Hodson EM; Knight JF; Willis NS; Craig JC
Cochrane Database Syst Rev; 2001; (2):CD001533. PubMed ID: 11405997
[TBL] [Abstract][Full Text] [Related]
12. Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.
Moxley RT; Ashwal S; Pandya S; Connolly A; Florence J; Mathews K; Baumbach L; McDonald C; Sussman M; Wade C; ;
Neurology; 2005 Jan; 64(1):13-20. PubMed ID: 15642897
[TBL] [Abstract][Full Text] [Related]
13. Calcium antagonists for Duchenne muscular dystrophy.
Phillips MF; Quinlivan R
Cochrane Database Syst Rev; 2008 Oct; (4):CD004571. PubMed ID: 18843663
[TBL] [Abstract][Full Text] [Related]
14. Corticosteroids for Bell's palsy (idiopathic facial paralysis).
Madhok VB; Gagyor I; Daly F; Somasundara D; Sullivan M; Gammie F; Sullivan F
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD001942. PubMed ID: 27428352
[TBL] [Abstract][Full Text] [Related]
15. Corticosteroids for treating nerve damage in leprosy.
Van Veen NH; Nicholls PG; Smith WC; Richardus JH
Cochrane Database Syst Rev; 2016 May; 2016(5):CD005491. PubMed ID: 27210895
[TBL] [Abstract][Full Text] [Related]
16. Corticosteroid therapy for nephrotic syndrome in children.
Hodson EM; Knight JF; Willis NS; Craig JC
Cochrane Database Syst Rev; 2000; (4):CD001533. PubMed ID: 11034723
[TBL] [Abstract][Full Text] [Related]
17. Rehabilitation interventions for foot drop in neuromuscular disease.
Sackley C; Disler PB; Turner-Stokes L; Wade DT
Cochrane Database Syst Rev; 2007 Apr; (2):CD003908. PubMed ID: 17443532
[TBL] [Abstract][Full Text] [Related]
18. Deflazacort for the treatment of Duchenne Dystrophy: a systematic review.
Campbell C; Jacob P
BMC Neurol; 2003 Sep; 3():7. PubMed ID: 12962544
[TBL] [Abstract][Full Text] [Related]
19. Deflazacort vs prednisone treatment for Duchenne muscular dystrophy: A meta-analysis of disease progression rates in recent multicenter clinical trials.
McDonald CM; Sajeev G; Yao Z; McDonnell E; Elfring G; Souza M; Peltz SW; Darras BT; Shieh PB; Cox DA; Landry J; Signorovitch J;
Muscle Nerve; 2020 Jan; 61(1):26-35. PubMed ID: 31599456
[TBL] [Abstract][Full Text] [Related]
20. Interventions for dysphagia in long-term, progressive muscle disease.
Jones K; Pitceathly RD; Rose MR; McGowan S; Hill M; Badrising UA; Hughes T
Cochrane Database Syst Rev; 2016 Feb; 2(2):CD004303. PubMed ID: 26859621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
